DOCSLIB.ORG

Corporate Governance Code (The Code) Issued by the Financial Reporting Council (FRC)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Corporate Governance Code (The Code) Issued by the Financial Reporting Council (FRC) 54 Strategic Report Governance Financial Statements Board of Directors Adrian Bellamy Rakesh Kapoor Adrian Hennah Nicandro Durante Chairman Chief Executive Officer Chief Financial Officer Non-Executive Director Nationality Nationality Nationality Nationality British/American Indian/British British Brazilian/Italian Length of tenure Length of tenure Length of tenure Length of tenure 17 years and one month Five years and three months Three years and 11 months Three years and one month Committee membership Committee membership Committee membership Committee membership Chair of Nomination; Corporate Nomination None Corporate Responsibility, Responsibility, Sustainability, Ethics Sustainability, Ethics and and Compliance; Remuneration Compliance; Remuneration Skills and experience Skills and experience Rakesh was appointed as CEO of Adrian joined RB in January Skills and experience the Company in 2011. He joined 2013 as Chief Financial Officer Skills and experience Adrian joined RB as Non- RB in 1987 and held a number of Designate, and was appointed Nicandro joined the RB Board Executive Director in 1999 and regional and central marketing CFO in February 2013. Adrian has in December 2013. He holds was appointed as Chairman of roles with the Company. In 2006 a wealth of financial experience; degrees in Finance, Economics the Board in May 2003. He brings he was appointed EVP, Category prior to joining RB, he spent six and Business Administration. extensive executive experience Development with responsibility years at Smith & Nephew plc He started his career working and was formerly Chairman of for global category management, as CFO and four years as CFO in finance in Brazil and joined the Body Shop International plc. R&D, media, market research and at Invensys plc. He worked for British American Tobacco (BAT) His other previous directorships strategic alliances. He has a wealth 18 years at GlaxoSmithKline in 1981. Whilst at BAT he has include River Island, The Gap Inc, of business experience and brings plc, holding a number of senior worked in the UK, Hong Kong and Gucci Group NV and The Robert to the Board valuable knowledge management and financial roles. Brazil. He held senior positions, Mondavi Corporation. of the Company. He started his career with PwC including Regional Director for (then Price Waterhouse) working in Africa and the Middle East, and Adrian earned his Bachelor of Rakesh holds an MBA from audit and consultancy and worked was appointed as Chief Operating Commerce and Master of Business XLRI, Jamshedpur and a with Stadtsparkasse Koeln, the Officer (COO) prior to his current Leadership degrees from the Chemical Engineering degree German regional bank. appointment. University of South Africa. from the Birla Institute of Technology and Science. Adrian has a degree in Law from Cambridge University and is a Sloan Fellow of the London Business School. Other current appointments Other current appointments Other current appointments Other current appointments Chairman of Williams-Sonoma Inc, None Non-Executive Director of RELX Chief Executive Officer of British and Chairman of the Supervisory Group plc and RELX NV. American Tobacco p.l.c. (BAT) Board of Action Nederland BV. since March 2011. Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements 2016 55 Strategic Report Governance Financial Statements Mary Harris Ken Hydon Dr Pamela Kirby André Lacroix Non-Executive Director Non-Executive Director Non-Executive Director Non-Executive Director Nationality Nationality Nationality Nationality British British British French Length of tenure Length of tenure Length of tenure Length of tenure One year and 11 months 13 years and one month One year and 11 months Eight years and three months Committee membership Committee membership Committee membership Committee membership Audit Chair of Audit; Nomination Chair of Corporate Responsibility, Audit; Nomination Sustainability, Ethics and Compliance; Audit; Nomination Skills and experience Skills and experience Skills and experience Mary was appointed as Non- Ken joined the RB Board as Non- André was appointed as Executive Director in February Executive Director in December Skills and experience Non-Executive Director of RB 2015. She was formerly a Partner 2003 and became Chairman of Pam joined RB as Non-Executive in October 2008. In June 2013 at McKinsey & Company, with a the Audit Committee in November Director in February 2015. She he became Senior Independent particular focus on consumer and 2006. He served as Senior served as Chairman of Scynexis Inc Director. He served as Chief retail businesses in China, South Independent Director between until June 2015. She was formerly Executive Officer of Inchcape plc East Asia and Europe. February 2005 and November CEO of Quintiles Transnational from 2006 until March 2015. He 2006. Ken’s career working in Corporation and held senior was previously Chairman and Chief Mary is a graduate of the the electronics, retail, consumer positions at AstraZeneca PLC and Executive Officer of Euro Disney University of Oxford (MA Politics, products and healthcare sectors Hoffman-La Roche. S.C.A., President of Burger King Philosophy and Economics) and brings valuable finance and International (previously part of Harvard Business School. business experience to the Board. Diageo), and also held positions He was formerly CFO of Vodafone at Colgate, PepsiCo and Ernst & Group plc and a former Non- Young LLP. Executive Director of Tesco plc and Pearson plc. André is a graduate of ESCP Europe. He is a Fellow of the Chartered Institute of Management Accountants, the Association of Chartered Certified Accountants and the Association of Corporate Treasurers. Other current appointments Other current appointments Other current appointments Other current appointments Non-Executive Director of ITV plc Non-Executive Director of Merlin Non-Executive Director of Chief Executive Officer of and J Sainsbury plc. Member Entertainments plc. DCC plc, Victrex plc, Hikma Intertek Group plc. of Supervisory Board of Pharmaceuticals PLC and a Unibail-Rodamco SE. member of the Supervisory Board of AkzoNobel N.V. Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements 2016 56 Strategic Report Governance Financial Statements Other Directors Board who served in of Directors the year continued Christopher Sinclair Judy Sprieser Warren Tucker Jaspal Bindra Non-Executive Director Non-Executive Director Non-Executive Director Non-Executive Director Appointed to the Board as Non-Executive Director in July 2014. Jaspal did not seek re-election at the 2016 Nationality Nationality Nationality AGM and stepped down as American American British Non-Executive Director of the Company. Length of tenure Length of tenure Length of tenure One year and 11 months 13 years and four months Six years and 10 months Committee membership Committee membership Committee membership Remuneration Chair of Remuneration; Audit Nomination Skills and experience Skills and experience Chris was appointed as Non- Skills and experience Warren was appointed as a Executive Director in February Judy joined the RB Board as Non-Executive Director in February 2015. Throughout his career he Non-Executive Director in August 2010. Warren was an Executive Sue Shim has held a number of executive 2003 and has been Chair of the Director and Chief Financial Officer Non-Executive Director positions and brings a wealth of Remuneration Committee since of Cobham plc from 2003 to 2013. Appointed to the Board as experience to the role. He was June 2004. She was previously Previously he was Non-Executive Non-Executive Director in previously Executive Chairman Director and Vice Chairman at Chairman at Paypoint plc, and has July 2014. Sue did not seek of Scandent Holdings, Executive Royal Ahold NV, CEO of Transora held senior finance positions at re-election at the 2016 AGM Chairman of Cambridge Solutions Inc. and Executive Vice President Cable & Wireless plc and British and stepped down as Non- Ltd, Chairman and CEO of Caribiner of Sara Lee Corporation and Airways plc. Executive Director of the International, and President and CFO of Sara Lee’s Food Group. Company. CEO at Quality Foods Centers, Inc. Warren is a Chartered Accountant Earlier in his career, he held various Judy has a Bachelor’s and and has an MBA from INSEAD. senior management positions Master’s degree from with PepsiCo, including Chairman Northwestern University. and CEO of Pepsi Cola Co., and Chairman of PepsiCo International Foods and Beverages, which gave him the platform to showcase his strong global branding skills. Chris is a graduate of the University of Kansas (Business Administration) and the Tuck Doug Tough School at Dartmouth College. Non-Executive Director Appointed to the Board as Other current appointments Other current appointments Other current appointments Non-Executive Director in Chairman of Mattel, Inc. Director of Allstate Corporation, Non-Executive Director of Thomas November 2014. Doug did not and InterContinental Exchange Inc. Cook Group PLC, Survitec seek re-election at the 2016 Limited and the UK Foreign & AGM and stepped down as Commonwealth Office. Non-Executive Director of the Company. Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements 2016 57 Strategic Report Governance Financial Statements Executive Committee Rakesh Kapoor Rupert Bondy Amedeo Fasano Chief Executive Officer Senior Vice President Executive Vice President, General Counsel/Company Supply Secretary Nationality Nationality Nationality
Load more

Recommended publications
  • Acquisition Agreement for Paras Pharmaceuticals -- Current
    Dealdoc Acquisition agreement for Paras Pharmaceuticals Paras Pharmaceuticals Reckitt Benckiser Dec 13 2010 © 2009-2021, Wildwood Ventures Ltd. All rights reserved. Acquisition agreement for Paras Pharmaceuticals Paras Pharmaceuticals Companies: Reckitt Benckiser Announcement date: Dec 13 2010 Deal value, US$m: 730.0 : acquisition value • Details • Financials • Termsheet • Press Release • Filing Data • Contract Details Announcement date: Dec 13 2010 Pharmaceutical Industry sectors: Consumer health Financials Deal value, US$m: 730.0 : acquisition value Termsheet 13 December 2010 Reckitt Benckiser has agreed to buy Paras forINR 32.6 billion (Indian Rupees) (approximately GBP 460 million). RB will finance the transaction from existing facilities. Press Release RB Buys India’s Paras Pharmaceuticals Ltd 13 December 2010 Reckitt Benckiser Group plc (RB) today announces that it has agreed to buy Paras Pharmaceuticals Limited (Paras) forINR 32.6 billion (Indian Rupees) (approximately GBP 460 million) from the current shareholders, including the Patel family and Actis, the emerging markets private equity investor. RB will finance the transaction from existing facilities. Paras is a privately-owned Indian company with a portfolio of leading Indian over the counter Health and Personal Care brands including: Moov, the No 2 topical analgesic pain ointment, D’Cold, the No 2 cold & flu remedy, Dermicool, the No 2 for prickly heat, Krack, the No 1 medicated skin treatment for cracked heels and Itch Guard and Ring Guard anti fungal creams. In addition, Paras has a personal care business led by Set Wet, a leading hair gel and deodorant brand. In the fiscal year ending March 2010, Paras generated net sales of INR 4,014 million, representing a mid-teens average growth rate over the last four years, and operating EBITDA for the same year of INR 1,083 million (approximately GBP 56 million and GBP 15 million respectively).
    [Show full text]
  • Rb-Annual-Report-2012.Pdf
    Reckitt Benckiser Group plc Reckitt Benckiser Group Healthier Happier Annual Report and Financial Statements 2012 Stronger Reckitt Benckiser Group plc Annual Report and Financial Statements 2012 Contents 1 Chairman’s Statement 2 Chief Executive’s Statement 10 Business Review 2012 18 Board of Directors and Executive Committee 19 Report of the Directors 22 Chairman’s Statement on Corporate Governance 24 Corporate Governance Report 30 Statement of Directors’ Responsibilities 31 Directors’ Remuneration Report 38 Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 39 Group income statement 39 Group statement of comprehensive income 40 Group balance sheet 41 Group statement of changes in equity 42 Group cash flow statement 43 Notes to the financial statements 75 Five-year summary 76 Parent Company – Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 77 Parent Company balance sheet 78 Notes to the Parent Company financial statements 84 Shareholder information Chairman’s Statement largest consumer health care category in The Board conducted its regular reviews the world with the acquisition of Schiff of the Company’s brands, geographic area Nutrition International, Inc. (Schiff) and and functional performance together with its leading US brands in the vitamins, detailed reviews of its human resources. minerals and supplements market. There The Board also completed its annual were also a few disposals of non core assessment of corporate governance assets. Net debt at the end of 2012, after including Board performance, corporate paying for dividends, net acquisitions and responsibility, and reputational and organisation restructuring, stood at business risk. £2,426m (2011: £1,795m). AGM Resolutions Your Board proposes an increase in the final The resolutions, which will be voted dividend of +11%, taking it to 78p per upon at our AGM of 2 May 2013 are share, and bringing the total dividend for fully explained in the Notice of Meeting.
    [Show full text]
  • RB Full Year 2017 Results Presentation
    RB Full Year 2017 Results Presentation 191919 ththth February 2018 Disclaimer Cautionary note concerning forwardforward----lookinglooking statements This presentation contains statements with respect to the financial condition, results of operations and business of RB (the “Group”) and certain of the plans and objectives of the Group that are forward-looking statements. Words such as ‘‘intends’, ‘targets’, or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including targets for net revenue, operating margin and cost efficiency, are forward-looking statements. Such statements are not historical facts, nor are they guarantees of future performance. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including many factors outside the Group’s control. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: the general economic, business, political and social conditions in the key markets in which the Group operates; the ability of the Group to manage regulatory, tax and legal matters, including changes thereto; the reliability of the Group’s technological infrastructure or that of third parties on which the Group relies; interruptions in the Group’s supply chain and disruptions to its production facilities; the reputation of the Group’s global brands; and the recruitment and retention of key management.
    [Show full text]
  • Rejuvenating RB Plc Group Benckiser Reckitt Annual Report and Financial Statements 2019 Statements Financial and Report Annual
    Rejuvenating RB Reckitt Benckiser Group plc Annual Report and FinancialStatements 2019 Reckitt Benckiser Group plc Annual Report and Financial Statements 20192018 INTRODUCTION CONTENTS Strategic Report Welcome 01 Financial highlights 02 Health and Hygiene Home – at a glance 04 Chairman’s statement 06 Chief Executive’s statement 10 Our business model Our purpose 12 How purpose drives our performance We exist to protect, heal and nurture in the relentless pursuit of a cleaner 14 Mapping what matters to our stakeholders and healthier world. 18 KPIs 20 Consumers Our fight 24 Customers We have a fight on our hands. A fight to make access to the highest quality 28 People hygiene, wellness and nourishment a right and not a privilege. 32 Partners 36 Communities 40 Environment 46 s172 statement 48 Health operating review 52 Hygiene Home operating review 56 Non-financial information statement 58 Financial review 64 Risk management Health 77 Viability statement Governance 78 Board of Directors 84 Executive Committee 86 Corporate Governance – Chairman’s statement 88 Corporate Governance statement 97 Nomination Committee Report 103 Audit Committee Report 111 CRSEC Committee Report 117 Directors’ Remuneration Report 138 Report of the Directors Page 48 141 Statement of Directors’ Responsibilities Financial Statements 143 Independent Auditors Report Chief Executive’s Statement 152 Financial Statements 223 Shareholder Information Hygiene Home Page 06 Page 52 STRATEGIC REPORT GOVERNANCE FINANCIAL STATEMENTS FINANCIAL HIGHLIGHTS Net Revenue Health Hygiene
    [Show full text]
  • Rb-Annual-Report-2017.Pdf
    Reckitt Benckiser Group plc(RB) Healthier Annual Report and Financial Statements 2017 Statements Financial and Report Annual Lives, Happier Homes Bringing Our Purpose to Life Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements 2017 RB is inspired by a vision of a world where people are healthier and live better. We continually invest and innovate to find new ways for people to look after themselves, their families and their homes. We believe passionately in doing things the right way and have a culture that pushes us to outperform, every day. Contents Strategic Report Transformation of RB page 01 Highlights 02 Our business model 04 Chairman’s Statement 6 06 Chief Executive’s Statement 10 Strategic objectives, targets and key performance indicators 14 betterbusiness in action 20 bettersociety in action 22 betterenvironment in action 24 Operating review 30 Megatrends 32 Health 34 Hygiene Home Strategy page 36 Financial review 42 Our framework for risk management betterbusiness 10 Governance 52 Board of Directors 56 Executive Committee bettersociety 58 Corporate Governance– Chairman’s Statement 61 Corporate Governance Statement betterenvironment 69 Nomination Committee Report 71 Audit Committee Report 76 Corporate Responsibility, Sustainability, Ethics and Compliance Committee Report Mead Johnson Nutrition Sale of 78 Directors’ Remuneration Report integration RB Food 82 Remuneration Policy at a glance 83 Implementation of specific commitments made to page Shareholders for 2017 84 Annual Report on Remuneration 95 Report
    [Show full text]
  • Hutchison China Meditech ("Chi-Med") (AIM: HCM)
    Press Cutting Publication: FT.com Date: 13 February 2013 Reckitt gets taste for Chinese remedy By Adam Jones Reckitt Benckiser has bought a manufacturer of traditional Chinese sore-throat remedies as part of a drive to add more holistic treatments to its stable of western healthcare brands. The UK-headquartered maker of Nurofen painkillers, Strepsils lozenges and Durex condoms on Wednesday said it had acquired Oriental Medicine Company for an undisclosed sum. Reckitt said the cost was modest as it announced the deal in annual results, featuring a 2 per cent increase in pre-tax profits compared with 2011 and a 7 per cent rise in the dividend. However, it still represents an eye-catching diversification for a western consumer goods group and comes in the wake of Reckitt’s purchase of Schiff Nutrition International, a US vitamin company, for $1.4bn late last year. Rakesh Kapoor, chief executive, said Reckitt had to keep up with changing consumer behaviour: “People think about their health in much more holistic terms. It is about how do you lead a more balanced life.” Oriental Medicine’s main remedy was a sore-throat powder, he said. The company makes all its sales in China, the group added. Western companies have been showing growing interest in China’s traditional medicine sector. In November Nestlé agreed a tie-up with a traditional Chinese medicine company controlled by Hong Kong billionaire Li Ka-shing. Although Reckitt one day hopes to use Oriental Medicine as a sales platform for its western healthcare products in China, Mr Kapoor said it was too early to say if Reckitt would seek to sell traditional Chinese remedies outside China.
    [Show full text]
  • Lna 2006 Profiles J.Qxp
    1 | Advertising Age | June 26, 2006 SpecialSpecial ReportReport:100 Profiles LEADING NATIONAL ADVERTISERSSupplement SUPPLEMENT June 26, 2006 100 LEADING NATIONAL ADVERTISERS Profiles of the top 100 U.S. marketers in this 51st annual ranking INSIDE TOP 100 RANKING COMPANY PROFILES SPONSORED BY The nation’s leading marketers Lead marketing personnel, ranked by U.S. advertising brands, agencies, agency expenditures for 2005. contacts, as well as advertising Includes data from TNS Media spending by media and brand, Intelligence and Ad Age’s sales, earnings and more for proprietary estimates of the country’s 100 largest unmeasured spending. PAGE 8 advertisers PAGE 10 This document, and information contained therein, is the copyrighted property of Crain Communications Inc. and The Ad Age Group (© Copyright 2006) and is for your personal, non-commercial use only. You may not reproduce, display on a website, distribute, sell or republish this document, or information contained therein, without prior written consent of The Ad Age Group. Are proud to connect you with the leading CMOs See all the interviews at adage.com/point LAUNCHING JUNE 28 © 2006 Crain Communications Inc. www.adage.com 3 | Advertising Age | June 26, 2006 Special Report 100 LEADING NATIONAL ADVERTISERS SUPPLEMENT ABOUT THIS PROFILE EDITION THE 51ST ANNUAL 100 Leading National the Top 100 ($40.13 billion) and for all measured spending in 18 national media, Advertisers Report crowned acquisition- advertisers ($122.79 billion) in the U.S. Yellow Pages Association contributed ladened Procter & Gamble Co. as the top U.S. ad spending by ad category: This spending in Yellow Pages and TNS Marx leader, passing previous kingpen General chart (Page 6) breaks out 18 measured Promotion Intelligence provided free- Motors Corp.
    [Show full text]
  • RB Enhances Consumer Health Position with the Completion of Its Acquisition of the Mead Johnson Nutrition Company
    Contacts: Lynn Kenney – Communications Director, RB North America P: +1 201-953-5348 [email protected] UK +44 (0)1753 217 800 Richard Joyce – SVP, Investor Relations Patty O’Hayer - Director, External Relations and Government Affairs RB enhances consumer health position with the completion of its acquisition of the Mead Johnson Nutrition Company Parsippany, NJ – June 15, 2017 – RB is pleased to announce the completion of the acquisition of the Mead Johnson Nutrition Company (“Mead Johnson”). The transaction takes RB into a global market leadership position in consumer health and hygiene. Mead Johnson brings the addition of two infant and child nutrition Powerbrands Enfa and Nutramigen, and is a natural extension of RB’s existing health portfolio which is trusted around the globe by millions of consumers. Rakesh Kapoor, RB chief executive, said: “The closure of the acquisition marks an inflection point in RB’s evolution to become a leader in consumer health care. By combining the best of RB’s global scale with MJN’s science-based innovation, RB is well positioned to deliver further value for all stakeholders. We continue to execute on our strategy of providing innovative health solutions for healthier lives and happier homes to millions of people around the world.” Mead Johnson will initially operate as a separate division within RB and be led by Aditya Sehgal, who joins RB’s Executive Committee. Aditya’s previous roles included responsibility for RB’s operations in China and North Asia, RB’s global health care division and RB’s North American business. The Mead Johnson division will continue its mission to nourish the world’s children for the best start in life.
    [Show full text]
  • Annual Report and Financial Statements 2016 Reckitt Benckiser Group Plc (RB) Annual Report and Financial Statements 2016
    Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements 2016 Reckitt Benckiser Group plc (RB) plc Group Benckiser Reckitt Annual Report and Financial Statements 2016 Purpose with a passion Reckitt Benckiser Group plc (RB) Annual Report and Financial Statements 2016 RB has a vision of a world where people are healthier and live better lives. Inspired by our purpose and a passionate culture that drives ownership and rewards success, we push ourselves to outperform, every day. Our purpose Our passion Our performance See more on pages See more on pages 4-5 See more on pages 6-7 2-3 2 3 4 5 6 7 Strategic Report Strategic Report Strategic Report Strategic Report Strategic Report Strategic Report Governance Governance Governance Governance Governance Governance Financial Statements Financial Statements Financial Statements Financial Statements Financial Statements Financial Statements Why RB delivers Our purpose… …combined with …drives our (out) Right portfolio strategy We identify unmet consumer needs, drive growth through innovation and invest our passion performance disproportionately behind our high-potential markets (Powermarkets) and our faster- growing brands (Powerbrands). Our purpose inspires us and informs what we do. RB has a unique culture that harnesses Bringing together passionate people and With every decision, we look for innovative solutions that Our purpose is to make the passion of our people. We have a compelling We want our people to behave as giving them a clear purpose makes RB a business where Powerbrands Powermarkets can help our consumers to live better, from new products a difference, by giving people desire to challenge ourselves and each other, if they own the business.
    [Show full text]
  • Annual Report and Financial Statements 2005 Statements and Financial Annual Report B
    THE BUSINESS Reckitt Benckiser plc Reckitt Benckiser plc 103-105 Bath Road, Slough, Berkshire SL1 3UH United Kingdom www.reckittbenckiser.com Annual Report and Financial Statements 2005 ANNUAL REPORT AND FINANCIAL STATEMENTS 2005 WE ARE PASSIONATE ABOUT DELIVERING BETTER SOLUTIONS IN HOUSEHOLD CLEANING AND HEALTH & PERSONAL CARE TO CUSTOMERS AND CONSUMERS, WHEREVER THEY MAY BE, FOR THE ULTIMATE PURPOSE OF CREATING SHAREHOLDER VALUE. CONTENTS 2 Report of the Directors 7 Financial review 2005 10 Directors’ remuneration report 16 Independent auditors’ report to the shareholders of Reckitt Benckiser plc 17 Accounting policies 20 Group income statement 20 Group statement of recognised income and expense 21 Group balance sheet 22 Group cash flow statement 23 Notes to the accounts 49 Five year summary 50 Parent company – independent auditors’ report to the shareholders of Reckitt Benckiser plc 51 Parent company accounting policies Designed and produced by The Workroom www.workroom.co.uk 52 Parent company balance sheet Printed by the colourhouse. The paper used throughout this report is manufactured from ECF (Elemental Chlorine Free) pulps sourced from 53 Notes to the parent company accounts sustainable managed forests. The recyclable outer wrapping used is 60 Shareholder information manufactured using totally degradable polythene. THE REPORT ANNUAL REPORT AND FINANCIAL STATEMENTS 2005 1 Reckitt Benckiser Annual Report and Financial Statements 2005 REPORT OF THE DIRECTORS The Directors submit their fifty-third Annual Report to the members to the Directors by shareholders at the Annual General Meeting of the Company, with the audited financial statements for the year held on 5 May 2005 to make such purchases up to a maximum ended 31 December 2005.
    [Show full text]
  • Press Release JAB Organizational Changes
    JAB Announces Organizational Changes as Part of Global Expansion Bart Becht to Retire in 2019; Peter Harf and Olivier Goudet To Continue to Lead JAB Fabien Simon, Ricardo Rittes and Jacek Szarzynski to Join the JAB Partnership LUXEMBOURG - January 14, 2019 - JAB today announced the retirement of Bart Becht during 2019. Peter Harf and Olivier Goudet will continue to lead JAB and oversee its investment strategy. JAB also welcomes consumer industry veterans Fabien Simon, Ricardo Rittes and Jacek Szarzynski to the JAB Partnership, where they will play key roles in continuing JAB’s strategy of long-term value creation. “Bart has been a valued member of the JAB team for many decades,” said Mr. Harf. “Having worked with him since our days at RB, I will miss our day-to-day interactions on a personal level but wish him all the best during his well-deserved retirement.” “I deeply appreciate Bart’s dedication to working with our portfolio companies over the years and thank him for his contribution to JAB,” said Mr. Goudet. “At the same time we are excited to further strengthen our team with Fabien, Ricardo and Jacek, all of whom have impeccable track records of long- term shareholder value creation in the consumer industry.” "After almost 40 years in the branded consumer business, I have decided it is time to refocus my activities and retire,” said Mr. Becht. “It has been a tremendous privilege and pleasure to work with JAB and the many people within its portfolio companies and I wish them continued success.” Fabien Simon, a French national, will become Partner and Chief Financial Officer (“CFO”) of JAB.
    [Show full text]
  • Q4 2012 Earnings Call YTD Change(%): +17.762 Bloomberg Estimates - Sales Current Quarter: 2452.000 Current Year: 10080.417
    Company Name: Reckitt Benckiser Market Cap: 32,863.50 Bloomberg Estimates - EPS Company Ticker: RB/ LN Current PX: 4568.00 Current Quarter: N.A. Date: 2013-02-13 YTD Change($): +689.00 Current Year: 2.618 Event Description: Q4 2012 Earnings Call YTD Change(%): +17.762 Bloomberg Estimates - Sales Current Quarter: 2452.000 Current Year: 10080.417 Q4 2012 Earnings Call Company Participants • Rakesh Kapoor • Adrian N. Hennah • Heather Allen Other Participants • Rosie A. Edwards • Jeremy D. Fialko • Celine Pannuti • Harold P. Thompson • James Edwardes Jones • Eduardo Santos • Robert R. Waldschmidt MANAGEMENT DISCUSSION SECTION Rakesh Kapoor Right. Are we ready to start? So good morning, everyone, and thank you very much for coming for our 2012 full-year results presentation. I have two people on the stage with me. I'd like to first introduce Heather Allen, who's been with Reckitt Benckiser for 17 years, with a very illustrious career spanning many general management assignments in category also. And now she's heading our global category organization, a job that she took over from me nearly two years ago and one that she's going to show the passion for our innovation as she talks about it later in the presentation. I also have Adrian Hennah, who's obviously not very new to many of you people, although he's new of course in Reckitt Benckiser. When he came into the company in January, first day of January, I said, Adrian, you know, don't worry too much about the full-year results presentation. I'll lead with the whole thing, including the financial parts, and he very bravely but at the same time very worried looked on his face when I told him I'll look up to the financial side, also looked very, very worried.
    [Show full text]